ZimVie Inc. (NASDAQ:ZIMV) Short Interest Down 21.5% in September

ZimVie Inc. (NASDAQ:ZIMV - Get Free Report) saw a significant decline in short interest in September. As of September 30th, there was short interest totalling 432,300 shares, a decline of 21.5% from the September 15th total of 550,900 shares. Based on an average daily trading volume, of 333,800 shares, the short-interest ratio is currently 1.3 days. Currently, 1.6% of the shares of the company are short sold.

ZimVie Price Performance

ZIMV traded up $0.38 on Friday, reaching $16.00. 85,442 shares of the company's stock were exchanged, compared to its average volume of 170,922. The stock has a market cap of $441.12 million, a PE ratio of -1.21 and a beta of 2.12. ZimVie has a twelve month low of $6.52 and a twelve month high of $22.40. The stock's fifty day moving average price is $16.66 and its 200-day moving average price is $17.07. The company has a debt-to-equity ratio of 0.62, a current ratio of 1.94 and a quick ratio of 1.43.

ZimVie (NASDAQ:ZIMV - Get Free Report) last posted its quarterly earnings results on Thursday, August 1st. The company reported $0.13 earnings per share for the quarter, missing analysts' consensus estimates of $0.17 by ($0.04). The business had revenue of $116.81 million for the quarter. ZimVie had a positive return on equity of 2.21% and a negative net margin of 63.84%. During the same quarter in the previous year, the firm earned $0.17 EPS. Sell-side analysts expect that ZimVie will post 0.63 EPS for the current year.

Insider Buying and Selling at ZimVie

In other news, major shareholder Camber Capital Management Lp sold 525,000 shares of the business's stock in a transaction dated Friday, August 2nd. The shares were sold at an average price of $17.71, for a total transaction of $9,297,750.00. Following the completion of the sale, the insider now owns 2,725,000 shares of the company's stock, valued at $48,259,750. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 3.01% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On ZimVie

A number of institutional investors and hedge funds have recently bought and sold shares of ZIMV. Scarborough Advisors LLC acquired a new position in ZimVie in the 4th quarter valued at about $28,000. Quarry LP boosted its holdings in ZimVie by 337.8% in the 2nd quarter. Quarry LP now owns 1,655 shares of the company's stock valued at $30,000 after purchasing an additional 1,277 shares during the last quarter. Summit Securities Group LLC boosted its holdings in ZimVie by 518.6% in the 2nd quarter. Summit Securities Group LLC now owns 3,000 shares of the company's stock valued at $55,000 after purchasing an additional 2,515 shares during the last quarter. Heritage Wealth Advisors boosted its holdings in ZimVie by 172,750.0% in the 1st quarter. Heritage Wealth Advisors now owns 6,914 shares of the company's stock valued at $114,000 after purchasing an additional 6,910 shares during the last quarter. Finally, SG Americas Securities LLC acquired a new position in ZimVie in the 3rd quarter valued at about $152,000. 95.63% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Separately, Needham & Company LLC boosted their target price on shares of ZimVie from $20.00 to $23.00 and gave the stock a "buy" rating in a research note on Friday, August 2nd.

About ZimVie

ZimVie Inc, together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It operates through two segments, The Dental Segment and The Spine Segment.